ProSciento está buscando adultos con diagnóstico de diabetes tipo 2 para participar en un estudio de investigación remunerado en San Diego, CA

No es necesario tener seguro médico para participar. ¡Comience el proceso hoy mismo! 

Para participar en este estudio de investigación remunerado, deberá completar un cuestionario telefónico sencillo de 20 minutos sobre usted y su estado de salud actual.

Usaremos esta información para averiguar si es elegible para este estudio o para cualquier otro estudio de investigación remunerado y con inscripción abierta en nuestro centro de investigación.

Nos complace responder a cualquier pregunta que pueda tener, y le proporcionaremos todos los detalles sobre el estudio durante su llamada telefónica con nuestro equipo de atención médica atento y altamente capacitado.

We are partnering with City of Hope® to look for adults living with Type 1 Diabetes to take part in their
research study to evaluate an experimental personalized immunotherapy (vaccine) for type 1 diabetes. All
study activities will take place at City of Hope® campus in Duarte, California.

The PIpepTolDC vaccine is a type of immunotherapy (a treatment that uses a person’s own immune system). The vaccine is made using your own immune cells and a beta cell protein. The vaccine may help your beta cells recover and make enough insulin to control your blood sugar levels. The vaccine may also help reduce future type 1
diabetes-related complications.

You’ll need to complete a risk-free, 20-minute phone call with one of our team members to see if you are
eligible. No health insurance is needed to participate!

If you are overweight, you may qualify to participate in a clinical research study. Volunteers may receive a stipend up to $4,150 for their time.  Your participation could last approximately 32 weeks and include up to two (4-day) in-house stays. You may also be considered for future research studies at ProSciento. Our research facility is located in Chula Vista, California. 

This study is to evaluate a new investigational medication being developed as a new option for people with Non-Alcoholic Steatohepatitis (NASH) who carry a specific gene we are looking to identify.

If you’ve been diagnosed with type 2 diabetes, you may qualify to participate in a clinical research study. Volunteers may receive a stipend up to $4,150 for their time.  Your participation could last approximately 32 weeks and include up to two (4-day) in-house stays. You may also be considered for future research studies at ProSciento. Our research facility is located in Chula Vista, California. 

This study is to evaluate a new investigational medication being developed as a new option for people with Non-Alcoholic Steatohepatitis (NASH) who carry a specific gene we are looking to identify.